UNSPSC 51392405: Ibopamine

This classification denotes a vasodilating agent with the molecular formula C17H25NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3VXW2HU8GS, chemically known as propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester but generally known as ibopamine, which bears US NIH Compound Identifier 68555. European Medicines Agency schedules Ibopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08094MIG. The term IBOPAMINE HYDROCHLORIDE is an International Non-Proprietary Name.

UNSPSC 51392405 Ibopamine, a Commodity code, appears in state and local procurement records tagged to pharmaceutical and medical-supply purchases, though the recent opportunity on file does not align with the code's nominal scope. The single recent solicitation—Seminole County, Florida's IFB60459723LAS for naloxone and safe drug deactivation systems—falls outside the ibopamine category entirely, suggesting either a data-tagging error or a mismatch between how the jurisdiction classified the procurement and the actual product family being bought. State and local health departments and county health agencies do procure pharmaceuticals and medical supplies through competitive bidding, typically via IFB or RFQ processes with fixed terms, renewal options, and standard insurance and compliance requirements, but the ibopamine code shows minimal verifiable recent activity aligned with its definition.

Seminole County, Florida posted the sole recent opportunity in this dataset on June 30, 2026, with a response deadline of July 26, 2023 (a date already passed as of today). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, on a two-year initial term with one-year renewal option. The procurement required E-Verify compliance, drug-free workplace certification, and standard liability and workers' compensation insurance, with potential FEMA funding and associated federal compliance obligations. Until further recent opportunities surface under this code, the ibopamine category shows no active decision-relevant state and local procurement signal.